Dow Jones

42,840.26

1.18%

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

VOR

Vor Biopharma (VOR)

Vor Biopharma Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:VOR

1 2 3 4 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
09/12/2024	06:39	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VOR	Vor Biopharma Inc
09/12/2024	06:30	GlobeNewswire Inc.	Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design	NASDAQ:VOR	Vor Biopharma Inc
14/11/2024	15:33	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:VOR	Vor Biopharma Inc
12/11/2024	07:00	GlobeNewswire Inc.	Vor Bio to Participate in the Stifel 2024 Healthcare Conference	NASDAQ:VOR	Vor Biopharma Inc
08/11/2024	15:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VOR	Vor Biopharma Inc
07/11/2024	15:05	GlobeNewswire Inc.	Vor Bio Reports Third Quarter 2024 Financial Results and Provides Company Update	NASDAQ:VOR	Vor Biopharma Inc
07/11/2024	15:01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VOR	Vor Biopharma Inc
02/10/2024	15:16	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:VOR	Vor Biopharma Inc
30/09/2024	06:00	GlobeNewswire Inc.	Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han Choi, M.D., LL.M., as Chief Financial Officer	NASDAQ:VOR	Vor Biopharma Inc
05/09/2024	15:01	GlobeNewswire Inc.	New Clinical Data Validates Vor Bio’s Approach of Using Shielded Transplants to Deliver Targeted Therapies	NASDAQ:VOR	Vor Biopharma Inc
28/08/2024	07:00	GlobeNewswire Inc.	Vor Bio to Participate in Upcoming Investor Conferences	NASDAQ:VOR	Vor Biopharma Inc
08/08/2024	15:13	Edgar (US Regulatory)	Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]	NASDAQ:VOR	Vor Biopharma Inc
08/08/2024	15:05	GlobeNewswire Inc.	Vor Bio Reports Second Quarter 2024 Financial Results and Provides Company Update	NASDAQ:VOR	Vor Biopharma Inc
02/08/2024	15:01	GlobeNewswire Inc.	Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:VOR	Vor Biopharma Inc
19/07/2024	16:04	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VOR	Vor Biopharma Inc
09/05/2024	15:05	GlobeNewswire Inc.	Vor Bio Reports First Quarter 2024 Financial Results and Provides Company Update	NASDAQ:VOR	Vor Biopharma Inc
02/05/2024	15:01	GlobeNewswire Inc.	Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors	NASDAQ:VOR	Vor Biopharma Inc
20/03/2024	15:05	GlobeNewswire Inc.	Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update	NASDAQ:VOR	Vor Biopharma Inc
14/02/2024	15:08	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:VOR	Vor Biopharma Inc
07/02/2024	07:00	GlobeNewswire Inc.	Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference	NASDAQ:VOR	Vor Biopharma Inc
17/01/2024	15:01	GlobeNewswire Inc.	Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate Update	NASDAQ:VOR	Vor Biopharma Inc
27/11/2023	07:00	GlobeNewswire Inc.	Vor Bio to Participate in the JMP Securities Hematology and Oncology Summit	NASDAQ:VOR	Vor Biopharma Inc
09/11/2023	15:01	GlobeNewswire Inc.	Vor Bio Presents Positive Data Update on Trem-cel at HSCT² Conference	NASDAQ:VOR	Vor Biopharma Inc
07/11/2023	15:05	GlobeNewswire Inc.	Vor Bio Reports Third Quarter 2023 Financial Results and Provides Company Update	NASDAQ:VOR	Vor Biopharma Inc
02/11/2023	08:01	GlobeNewswire Inc.	Multiple Clinical and Preclinical Presentations at ASH 2023 Highlight Vor Bio’s Novel eHSC and CAR-T Platform	NASDAQ:VOR	Vor Biopharma Inc
30/08/2023	15:51	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:VOR	Vor Biopharma Inc
10/08/2023	15:05	GlobeNewswire Inc.	Vor Bio Reports Second Quarter 2023 Financial Results and Provides Company Update	NASDAQ:VOR	Vor Biopharma Inc
01/08/2023	07:00	GlobeNewswire Inc.	Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference	NASDAQ:VOR	Vor Biopharma Inc
09/06/2023	06:42	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VOR	Vor Biopharma Inc
09/06/2023	06:30	GlobeNewswire Inc.	Successful Primary Engraftment of Trem-cel in First Five AML Patients Demonstrates Promise of Vor Bio’s Platform	NASDAQ:VOR	Vor Biopharma Inc